Catalyst Wire Dossier Catalyst Wire Dossier

Vahelva Respimat

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vahelva Respimat, covering 2022-01-19 to 2022-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease

See pricing